πŸ‡ΊπŸ‡Έ FDA
Patent

US 6998413

Treatment of neoplasms with yujungamycins

expired A61KA61K31/415

Quick answer

US patent 6998413 (Treatment of neoplasms with yujungamycins) held by ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/415